Top
Image Alt

The Investing Box

  /  Editor's Pick   /  RAD 202 receives approval to start Phase 1 therapeutic trial

What's your reaction?

Cool
0
Dislike
0
Dislike
0
Geeky
0
Geeky
0
Like
0
Like
0
LOL
0
Love
0
Love
0
NSFW
0
NSFW
0
OMG
0
OMG
0
WTF
0

RELATED POSTS

Editor's Pick, Stock

The S&P/TSX Venture Composite Index (INDEXTSI:JX) fell 2.87 percent on the week to close at 586.88

Editor's Pick, Stock

(TheNewswire) December 20th, 2024 Vancouver, B.C. TheNewswire – Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD)

Editor's Pick, Stock

The silver price reached highs not seen since 2012 this past year, supported by an ongoing